Glucocorticoid receptor; Muscarinic M3; Beta-2 adrenergic
Assets acting on this target.
- Class
- Inhaled corticosteroid, long-acting muscarinic antagonist and long-acting beta2-agonist triple combination
- Notes
- hand ruling, audit finding #1861; Breztri held FIVE links, including a short-acting beta-2 row and a short-acting muscarinic row for a drug whose two bronchodilators are both long-acting. All are replaced by one row naming all three components; source: https://api.fda.gov/drug/label.json?search=openfda.brand_name:%22BREZTRI%22&limit=3
Related mechanisms
Glucocorticoid receptor / Beta-2 adrenergic receptor / Muscarinic M3 receptor (ICS/LABA/LAMA triple combination) (2)Glucocorticoid receptor / Beta-2 adrenergic receptor (4)Muscarinic M3 receptor / Beta-2 adrenergic receptor (combination) (2)5-HT2A, α1-adrenergic, H1-histaminergic, and M1-muscarinic acetylcholine receptors (functional antagonism) (1)Glucocorticoid receptor; β2-adrenergic receptor (1)Muscarinic acetylcholine receptor M3 and beta-2 adrenergic receptor (1)